SCHEMBL3846543

SCHEMBL3846543

CS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4cccc(C#N)c4)cc23)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 12/20 0.38
CYP3A4 P08684 10/20 0.38
CLK4 Q9HAZ1 8/20 0.38
ALDH1A1 P00352 8/20 0.38
MAP4K4 O95819 1/20 0.37
HSD17B10 Q99714 8/20 0.37
USP2 O75604 5/20 0.37
HIF1A Q16665 5/20 0.37
CYP2D6 P10635 5/20 0.37
CYP2C9 P11712 5/20 0.37
LMNA P02545 4/20 0.37
TSHR P16473 4/20 0.37
MAPK1 P28482 3/20 0.37
TP53 P04637 3/20 0.37
RECQL P46063 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SCN9A Q15858 1/20 0.35
AKT1 P31749 2/20 0.34
CYP2C19 P33261 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849245 0.93 MAP4K4 (0.33) CYP1A2CYP3A4CLK4ALDH1A1MAP4K4
SCHEMBL3850715 0.89 CYP1A2 (0.32) CYP1A2CYP3A4CLK4ALDH1A1HSD17B10
SCHEMBL3846261 0.87 CA12 (0.34) CYP1A2CYP3A4CLK4ALDH1A1USP2
SCHEMBL3853047 0.86 CA12 (0.32) CYP1A2CYP3A4CLK4ALDH1A1MAP4K4
SCHEMBL3854489 0.86 PTGS2 (0.35) CYP1A2CYP3A4MAP4K4HIF1ACYP2D6
SCHEMBL3846545 0.86 CYP1A2 (0.33) CYP1A2CYP3A4CLK4ALDH1A1MAP4K4
SCHEMBL3854275 0.86 CYP3A4 (0.33) CYP1A2CYP3A4CLK4ALDH1A1HSD17B10
SCHEMBL3855967 0.85 PIK3CD (0.41) CYP1A2CYP3A4CLK4ALDH1A1MAP4K4
SCHEMBL3845263 0.85 CYP1A2 (0.34) CYP1A2CYP3A4CLK4ALDH1A1HSD17B10
SCHEMBL3847026 0.85 STK17B (0.32) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed